Default Category
-
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
Herzlinger, Regina E.; Otazo, AndrewCase HBS-315045-EEntrepreneurshipA medical device startup seeks to complete its clinical trials with very little startup funding and a small staff when compared to its competitors.Starting at €8.20
-
Tapping the Power of Analogy (Spanish version)
Gavetti, Giovanni; Rivkin, Jan W.Article HBS-R0504CStrategyRecognize the analogy and identify its purpose; thoroughly understand its source; determine whether the resemblance is more than superficial; and decide whether the original strategy, properly translated, will work in the target industry.Starting at €8.20
-
Matching Dell (Spanish version)
Rivkin, Jan W.; Porter, Michael E.Case HBS-702S06StrategyAfter years of success with its vaunted "Direct Model" for computer manufacturing, marketing, and distribution, Dell Computer Corp. faces efforts by competitors to match its strategy. The case 'Matching Dell' describes the evolution of the personal computer industry, Dell's strategy, and efforts by Compaq, IBM, Hewlett-Packard, and Gateway 2000 to capture the benefits of Dell's approach. Students are called on to formulate strategic plans of acti...Starting at €8.20
-
Microsoft's Search (Spanish version)
Rivkin, Jan W.; Van Den Steen, EricCase HBS-710S03StrategyIn 2008, executives at Microsoft must decide how to compete against Google in the market for Internet search and advertising. The case describes how Microsoft has responded to a set of competitive threats in the past; how Google has gained a dominant position in Internet search and advertising; and what Microsoft has done so far in its as-yet-unsuccessful effort to catch up with Google. The case then challenges students to construct a strategy th...Starting at €8.20
-
The Looming Challenge to U.S. Competitiveness
Porter, Michael E.; Rivkin, Jan W.Article HBS-R1203B-EStrategyAlthough the U.S. retains profound competitive strengths--for instance, in higher education and entrepreneurship--those strengths are increasingly threatened by weaknesses in areas such as the tax code, basic education, macroeconomic policies, and regulation. Steps to reverse the loss will require a new focus by government and business leaders.Starting at €8.20
-
Mayo Clinic: The 2020 Initiative
Herzlinger, Regina E.; Huckman, Robert S.; Lesser, JennyCase HBS-615027-EDescribes the challenges facing Dr. John Noseworthy, President and CEO, in implementing a long-term strategy for the growth of the Mayo Clinic-a leading academic medical center with a reputation for excellence in tertiary and quaternary health care. The case highlights the concurrent forces of regional and national competition and federal health care reform as factors complicating the plans of Mayo Clinic to grow through several channels. Student...Starting at €8.20
-
McKesson
Herzlinger, Regina E.; Kindred, NatalieCase HBS-312002-EMcKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into health care services with the acquisition of U.S. Oncology, an integrated cancer care company, whose expertise it could leverage in offerings catered to other physician specialties. Wi...Starting at €8.20
-
Cancer Treatment Centers of America (A)
Herzlinger, Regina E.; Kindred, NatalieCase HBS-313012-EService and Operations ManagementCancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who were reached through advertising its integrative, team-based approach to care. CEO Stephen Bonner needed to decide whether to focus future expansion on building additional full-scale ...Starting at €8.20
-
Shanghai Pharmaceuticals
Herzlinger, Regina E.; Kindred, NatalieCase HBS-313016-EStrategyShanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company-essentially a collection of subsidiaries operating under a unified management structure-was formed through the 2009 merger of several state-owned enterprises, part of a broad policy effort in China to streamline state assets, ...Starting at €8.20
-